psoralidin
CAS: 18642-23-4
Ref. 3D-FP73918
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Product Information
- 3,9-Dihydroxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methyl-2-butenyl)-6H-benzofuro(3,2-c)(1)benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one
- 3,9-dihydroxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c]chromen-6-one
- 3-Benzofurancarboxylic acid, 2-[2,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl]-6-hydroxy-, δ-lactone
- 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-butenyl)-
- 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-
Psoralidin is a pharmacological agent that induces apoptosis in cancer cells. It binds to the response element of the pro-apoptotic gene, PUMA, and causes the activation of several proteins involved in the apoptosis pathway. It has been shown to successfully induce cell death in HL-60 cells and murine hepatoma cells. Psoralidin is also able to inhibit cancer cell proliferation by suppressing the expression of oncogenes such as MMP-2, MMP-9, and COX-2. The mechanism by which psoralidin induces apoptosis is not yet fully understood but may be due to its ability to induce endoplasmic reticulum stress or activate caspases.
Chemical properties
Technical inquiry about: 3D-FP73918 psoralidin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
